Abstract
Tuberculosis has been known to humans since time immemorial.1 The earliest written records of tuberculosis originate from India and China, dating as far back as 3300 years and 2300 years respectively.2,3 It is known by many names4, and is still a deadly disease affecting significant number of people worldwide. According to most recent estimates5, tuberculosis was diagnosed in 10 million people worldwide in 2017, and deaths attributable to tuberculosis in year 2017 among HIV-negative individuals were 1.3 million. Tuberculosis caused additional 0.3 million deaths among people living with HIV. Two-thirds of cases of tuberculosis in year 2017 were from eight countries and Pakistan contributed 5% of the global burden of tuberculosis in the year 2017.5 According to the World Health Organization (WHO), Pakistan is among the top 20 countries which collectively contributed 84% and 87% to the world-wide burden of drug-susceptible and drug-resistant tuberculosis respectively in year 2017.5 Infact, Pakistan contributes 61% of the cases of tuberculosis in the eastern Mediterranean region and has been estimated to have 4th highest burden of muti-drug resistant tuberculosis (MDR-TB) worldwide.
Dr. Munir Ahmad Abbasi,. (2018) GUIDELINES FOR THE TREATMENT OF DRUG RESISTANT TUBERCULOSIS: THE 2018 REVISION, JOURNAL OF AYUB MEDICAL COLLEGE ABBOTTABAD, Volume 30, Issue 4.
-
Views
429 -
Downloads
39
Next Article
Article Details
Volume
Issue
Type
Language
